03
Sun, Nov
45 New Articles

Life sciences in Romania, encompassing pharmaceuticals, biotechnology, and medical devices, is a sector marked by both significant challenges and promising opportunities. As the country continues to integrate into the European Union’s regulatory and economic frameworks and as those frameworks evolve and become more complex, Romania faces the constant task of aligning its local industry with European and international standards. This alignment is crucial for fostering innovation, ensuring public health, and attracting foreign investment. The industry’s growth is influenced by many factors, such as financing, pricing and reimbursement, regulatory compliance and product liability, and sustainable public procurement tools and processes.

Dorda, working with Linklaters, Kromann Reumert, and Wilson Sonsini Goodrich & Rosati, has advised Novo Holdings on its acquisition of Single Use Support. E+H advised the Single Use Support founders and Binder Groesswang advised Danaher on the sale side. Kirkland & Ellis reportedly advised Danaher as well.

More Articles ...